Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diselenide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102010282A details a green aqueous catalytic method for diaryl disulfides. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN104000828A reveals novel quinazoline diselenide salts with enhanced solubility and antitumor activity, offering scalable manufacturing solutions.
Patent CN102010282B reveals a green aqueous method for diaryl disulfide production. Achieve significant cost reduction in fine chemical manufacturing with scalable technology.
Novel photocatalytic method for organic selenium compounds offers high purity and cost-effective manufacturing for pharmaceutical intermediates supply chains.
Patent CN101619034B reveals a novel atmospheric pressure method for synthesizing diselenides using elemental selenium and carbon monoxide, offering significant cost reduction and safety improvements for pharmaceutical intermediate manufacturing.
Patent CN115919817B reveals electrochemical and iodine-catalyzed synthesis for high-purity gem-diselenide compounds, offering cost reduction and scalable supply chain solutions.
Patent CN111333558A details a catalyst-free visible light method for α-selenyl ketones. Discover cost-effective, scalable routes for high-purity pharmaceutical intermediates.
Patent CN102627614B details a robust synthesis of bisquinazoline diselenides. This report analyzes cost-effective manufacturing and supply chain reliability for oncology intermediates.
Novel metal-free synthesis enables cost reduction in pharmaceutical intermediate manufacturing with simplified process and enhanced scalability for reliable high-purity supply chains.
This patent introduces a metal-free synthesis of trifluoromethyl-selenium azaspiro compounds using Oxone promoter. It offers simplified manufacturing and enhanced supply chain reliability for pharmaceutical intermediates.
Solve high-cost synthesis challenges with this metal-free method for pharmaceutical intermediates. Eliminate heavy metal catalysts and reduce production risks. Contact for scalable manufacturing.
Solve high-cost, complex aryl diselenide synthesis with this green method. 95% yield, no anhydrous conditions, ethanol recyclable. Reduce supply chain risks for pharma R&D.
Discover cost-effective, metal-free synthesis of trifluoromethyl selenium azaspiro[4,5]-tetraenone with high yield and no heavy metal catalysts. Reduce supply chain risks for your pharmaceutical intermediates.